CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,087
- in 3 filings
Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-05 | Oney Sabah Chief Business Officer | Option exercise · Stock Option (right to buy) | −1,500 | 148,100 | ||
| 2019-12-03 | Yu Calvin Vice President, Finance | Sale | −1,315 | $18.31 | $24K | 175,294 |
| 2019-11-15 | King Robert Chief Development Officer | Sale | −7,500 | $15.92 | $119K | 522,317 |
| 2019-11-15 | Paul Robert Chief Medical Officer | Sale | −10,000 | $15.93 | $159K | 293,719 |
| 2019-11-06 | Oney Sabah Chief Business Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2019-11-06 | King Robert Chief Development Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2019-11-06 | Yu Calvin Vice President, Finance | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2019-11-06 | Rosenthal Arnon Chief Executive Officer | Grant or award · Stock Option (right to buy) | +520,000 | 520,000 | ||
| 2019-11-06 | Paul Robert Chief Medical Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2019-10-15 | Paul Robert Chief Medical Officer | Sale | −10,000 | $14.68 | $147K | 301,719 |
| 2019-09-20 | Oney Sabah Chief Business Officer | Option exercise | +400 | $8.16 | $3K | 594,318 |
| 2019-09-20 | Oney Sabah Chief Business Officer | Sale | −400 | $20.00 | $8K | 593,918 |
| 2019-09-20 | Oney Sabah Chief Business Officer | Option exercise · Stock Option (right to buy) | −400 | 149,600 | ||
| 2019-09-20 | Paul Robert Chief Medical Officer | Option exercise | +4,000 | $8.16 | $33K | 315,719 |
| 2019-09-20 | Paul Robert Chief Medical Officer | Sale | −4,000 | $20.00 | $80K | 311,719 |
| 2019-09-20 | Paul Robert Chief Medical Officer | Option exercise · Stock Option (right to buy) | −4,000 | 346,000 | ||
| 2019-09-16 | Paul Robert Chief Medical Officer | Sale | −10,000 | $19.08 | $191K | 311,719 |
| 2019-08-20 | Paul Robert Chief Medical Officer | Option exercise | +916 | $8.16 | $7K | 324,635 |
| 2019-08-20 | Paul Robert Chief Medical Officer | Sale | −916 | $16.00 | $15K | 323,719 |
| 2019-08-20 | Paul Robert Chief Medical Officer | Option exercise · Stock Option (right to buy) | −916 | 348,000 |
Page 30 of 36 · 702 trades